MedPath

A Clinical Study of Hyperthyroidism in Children

Recruiting
Conditions
Hyperthyroidism
Registration Number
NCT06570967
Lead Sponsor
Shengjing Hospital
Brief Summary

This study intends to conduct a retrospective and prospective study on children with hyperthyroidism, and it is a non-intervention study to collect information on diagnosis and treatment and long-term follow-up of children with hyperthyroidism. To investigate the clinical characteristics, treatment effect, side effects and remission of hyperthyroidism in children, to analyze the predictive factors for the effect of antithyroid drug treatment, remission and recurrence after drug withdrawal, and to explore the risk factors related to the occurrence of antithyroid drug-related adverse reactions.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  1. Age ≤14 years old
  2. Initial diagnosis of hyperthyroidism
Read More
Exclusion Criteria
  1. Hyperthyroidism had been treated with medication in other hospitals,
  2. History of autoimmune hepatitis, viral hepatitis, hematological diseases, bone marrow or liver transplantation,
  3. Patients with incomplete clinical data
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Remission of hyperthyroidism in children treated with methimazole. Remission is defined as having clinical and biochemical euthyroidism(FT3, FT4 and TSH are normal) without methimazole treatment for at least 12 months.10 years

To analyze the therapeutic effect of methimazole and the predictors of remission of hyperthyroidism after methimazole treatment.

Adverse effects of methimazole in the treatment of hyperthyroidism in children. Adverse effects are defined as having neutropenia (absolute neutrophil count< 1500/µL), liver dysfunction (AST or ALT> 60 IU/L), rash, arthralgia, myalgia, et al.1 year

Analyze the adverse reaction of methimazole treatment in hyperthyroidism children. Explore the risk factors related to the occurrence of methimazole related adverse reactions.

Secondary Outcome Measures
NameTimeMethod
Relapse of hyperthyroidism in children treated with methimazole. Relapse was defined as having clinical and biochemical hyperthyroidism (FT3 and FT4 increased and TSH decreased) after discontinuation of methimazole.10 years

The risk factors of relapse in children with hyperthyroidism treated with MMI were analyzed

Trial Locations

Locations (1)

Shengjing Hospital of China Medical University

🇨🇳

Shenyang, Liaoning, China

Shengjing Hospital of China Medical University
🇨🇳Shenyang, Liaoning, China
Ying Xin, Doctor
Contact
xin.ying168@live.cn
+8618940251876
© Copyright 2025. All Rights Reserved by MedPath